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Abstract 
The aim was to study the association of breastfeeding, age at introduction of foods and food 
diversity in infancy with advanced islet autoimmunity and type 1 diabetes. In the prospective 
Finnish Type 1 Diabetes Prediction and Prevention Study, 5,915 newborn infants with increased 
susceptibility to type 1 diabetes, recruited in 1996-2004, were included. Children were followed at 
3-12 month intervals for 4 islet autoantibodies and for type 1 diabetes up to the age of 15 years. 
Survival models were used for statistical analyses. Breastfeeding, age at introduction of any new 
food, or food diversity were not associated with advanced islet autoimmunity or type 1 diabetes in 
the cohort. Early introduction of solid foods was associated with increased risk of developing 
advanced islet autoimmunity in up to the age of 3 years (HR 2.33; 95% CI 1.39, 3.91 for <3 months 
and HR 2.18; 95% CI 1.38, 3.47 for 3-4 months vs. >4 months) but not in longer follow-up (P value 
for interaction=0.046). Similar results were observed for age at introduction of roots, cereals, egg 
and meat with advanced islet autoimmunity. To conclude, no consistent long-term associations 
between infant feeding and advanced islet autoimmunity or type 1 diabetes were observed. 
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Since the gut microbiota and immune system are immature at birth, very early introduction of 
supplemental foods have been implicated to trigger immune-mediated processes that may lead to 
type 1 diabetes (1-5). Early introduction of root vegetables, fruits or berries, or cereals have been 
inconsistently associated with islet autoimmunity in prospective studies in children with increased 
susceptibility to type 1 diabetes (2, 4, 6-9).  The inconsistent results may be related to association-
modifying effects of genes and breastfeeding (10-12). 
Only a few prospective studies have reported age at introduction of foods and risk of clinical type 1 
diabetes (7, 8, 12, 13), mostly in children carrying genetic susceptibility (7, 8, 12). In the US-based 
DAISY Study, early (<4 months) and late (≥6 months) introduction of solid foods was associated 
with increased risk of type 1 diabetes (12). In the Norwegian MIDIA Study, no significant 
associations were observed, except for a protective association of breastfeeding for 12 months or 
longer (7). The German BABYBIAB/BABYDIET Study reported an association between early (<3 
month) introduction of gluten containing cereals and type 1 diabetes (8).  
Higher food diversity could, in theory, modify the development of gut microbiota and immune 
system towards a healthier direction, and therefore decrease the risk of developing type 1 diabetes 
(1, 14). The association between higher food diversity in infancy and decreased risk of childhood 
allergic diseases  (15) encouraged us to study, whether food diversity would also associate with the 
risk of developing type 1 diabetes.  
We previously reported the associations between breastfeeding and age at introduction of foods 
with the development of advanced islet autoimmunity (4, 6). Now with a larger study population 
and longer follow-up, the primary aims were to study whether breastfeeding and age at introduction 
of complementary foods or food diversity in infancy are associated with advanced islet 
autoimmunity or type 1 diabetes. The secondary aims were to study, whether follow-up time and 
selected type 1 diabetes related genes modify the associations between infant dietary exposures and 
advanced islet autoimmunity or type 1 diabetes. 
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METHODS 
Study Design and Population 
This study is part of the Finnish Type 1 Diabetes Prediction and Prevention (DIPP) Study, which is 
a large population-based birth cohort study of children with Major Histocompatibility Complex, 
Class II (HLA)-conferred susceptibility to type 1 diabetes (16). In the DIPP Nutrition Study, 7782 
children born in the Tampere and Oulu University Hospitals between September 1996 and 
September 2004 were invited for follow-up (Web Figure 1). Children with genotypes HLA-
DQB1*02 ⁄ *03:02 and DQB1*03:02 ⁄ x (x stands for alleles other than DQB1*02 or DQB1*0602/3 
until March 1997 and other than DQB1*02 or DQB1*06:02 thereafter) were eligible for DIPP 
follow-up. The children were invited to study visits in 3 to 12 months intervals until the age of 15 
years or until the manifestation of type 1 diabetes. The inclusion criteria for the present report was 
having data on early feeding and islet autoimmunity and/or type 1 diabetes. To test the potential 
gene-modifying effects of INS and PTPN22, we used a nested case-control setting within the cohort. 
For 295 cases with advanced islet autoimmunity (in September 2012), we randomly selected 2 
controls matched with the cases for the date of birth within 3 months, sex, HLA-genotype and area 
of birth, who were islet cell antibody-negative and diabetes-free at the time the case turned out to be 
a case. Parents gave their written informed consent for genetic testing of their newborn from cord 
blood sample and for participation in the follow-up. The study adheres to the Declaration of 
Helsinki, and the local ethics committees have approved the study protocol. 
 
Dietary Assessment 
Parents completed age-specific dietary questionnaires and an “age at introduction of new foods” 
form at home. The form and the questionnaires were checked by a trained study nurse at study visits 
at 3, 6, 12, 18 and 24 months (4). The duration of breastfeeding, use of infant formulas, vitamin 
supplements and age at introduction of complementary foods were asked about. The duration of 
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exclusive breastfeeding was defined as the age when consuming any food or drink other than breast 
milk, water or dietary supplements, for the first time. Early exposure to any infant formula or cow’s 
milk based formula at hospital was considered as end of exclusive breastfeeding and first use of 
cow’s milk, respectively. Duration of any breastfeeding was the age, when child received breast 
milk for the last time. Introduction of a new food (cow’s milk or cow’s milk based infant formula 
(combined); potatoes; carrots; turnip; fruits or berries (combined); cereals (rye, wheat, oats, or 
barley combined); other cereals; meat; fish; egg; cabbage; spinach or beetroot (combined); and 
lettuce) was recorded with an accuracy of 0.5 months. The food diversity was the sum of these 13 
foods/food groups that the child had started to consume. Age at introduction of solid foods was the 
first introduction of any of the following: roots, fruits or berries, cereals, other cereals, meat, fish, 
egg, cabbage, spinach, beetroot and lettuce. Age at introduction of roots included carrots, potatoes 
and turnip. 
Advanced Islet Autoimmunity, Type 1 Diabetes and Progression to Type 1 Diabetes 
Children were screened for islet cell antibodies at 3 to 12-month intervals as described before (4). 
When a child seroconverted to positivity for islet cell antibodies for the first time, all preceding and 
subsequent samples from that participant were analyzed for insulin autoantibodies, glutamic acid 
decarboxylase and islet antigen-2 antibodies. Islet cell antibodies were quantified by a standard 
indirect immunofluorescence method, insulin autoantibodies, glutamic acid decarboxylase and islet 
antigen-2 antibodies with specific radiobinding assays. Advanced islet autoimmunity was defined as 
repeated positivity for islet cell antibody and at least 1other autoantibody, excluding 
transplacentally transferred autoantibodies. Children with type 1 diabetes were included in the 
group of children with advanced autoimmunity. Type 1 diabetes was defined according to World 
Health Organization criteria  (17). Risk of progression to type 1 diabetes was assessed among 
children with repeated positivity to at least 1 islet autoantibody (progression cohort). The number of 
cases for the whole cohort were updated between May 2014 and May 2015. 
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Genetic Methods 
HLA-DQ was genotyped using panels of sequence-specific oligonucleotide probes, as described 
before  (18). Genotypes HLA-DQB1(*02/*03:02) represent “high” and HLA-DQB1*03:02/x (x 
≠*02, *03:01, *06:02) “moderate” risk for type 1 diabetes. INS-23 A/T (rs689) and PTPN22 
1858C/T (rs2476601) were genotyped using the Sequenom platform, or using the TaqMan SNP 
genotyping array, with INS AA and PTPN22 TT/CT regarded as the risk genotypes for type 1 
diabetes (19). 
Demographic and Perinatal Characteristics 
Information on maternal vocational education and age, any type of diabetes in first-degree relative 
(=familial diabetes), and offspring sex was collected with a questionnaire after delivery. 
Information on the number of previous deliveries, gestational age, number of fetuses, birth weight 
and length (ponderal index was calculated as kg/m3), and maternal smoking during pregnancy was 
obtained from the medical birth registers of the university hospitals.  
Statistical Methods 
To study the associations between characteristics of the participants and dietary exposures with 
advanced islet autoimmunity, a piecewise linear log-hazard survival model was used (Web 
Appendix 1). The risk of type 1 diabetes in the whole cohort and in the progression cohort, were 
assessed with Cox proportional hazards regression analysis. For progression to the type 1 diabetes 
outcome, delayed entry into the risk set was incorporated into the model, i.e. subjects enter the 
analysis at the age of autoantibody positivity and exit at their event/censoring age. In the Cox 
models, dependence among siblings was taken into account by performing a marginal analysis with 
a working independence assumption and a robust sandwich estimator of variance.  
Age at introduction of each food as well as duration of exclusive and any breastfeeding were 
categorized into thirds, and the last third was used as the reference category. As all children are 
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unexposed at birth, the children shifted to their exposure category at the time of the introduction. 
Food diversity was categorized into 3 or 4 classes based on variable distributions, and the last class 
was used as the reference category. Results of the main analysis were adjusted for HLA risk 
genotype (high/moderate), familial diabetes (yes/no), child sex (boy/girl) and maternal education 
(none, vocational, secondary vocational, university studies or degree). The unadjusted sensitivity 
analyses were done for the breastfeeding variables: 1) division of the exposure variable into 
quarters, and 2) disregarding the hospital exposure to infant formula when the exclusive 
breastfeeding was divided in thirds. 
The proportionality of the hazards was tested by adding linear interaction terms of the dietary 
exposures with time to the models of advanced islet autoimmunity and type 1 diabetes. If there was 
any indication of an interaction (P < 0.05), then separate results at age categories 0-3, 3.1-6 and >6 
years were obtained to illustrate such time-varying effect. To study whether the HLA risk genotype 
modified the associations between dietary exposures and outcomes, we added interaction terms to 
the models. Separate results for HLA risk genotype categories are presented, if the interaction was 
significant (P < 0.05). Finally, conditional logistic regression analysis with interaction terms was 
used to study whether INS and PTPN22 genotypes modified the associations in the nested case-
control setting. 
SAS software version 9.3 (SAS Institute, Cary, NC, USA) was used in the analyses. Statistical 
significance was set at 2-sided P < 0.05. 
RESULTS 
Of the 6,081 participants enrolled, 5,915 had data on early feeding (Web Figure 1). Within these 
participants, the median (interquartile range) number of antibody measurements was 11 (5, 16) per 
child. Altogether, 359 children had developed advanced islet autoimmunity or type 1 diabetes at a 
median age of 4.0 (2.0, 7.2), and 188 children had developed type 1 diabetes at a median age of 6.0 
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(3.8, 9.2) years. There were 975 children with repeated positivity for at least 1 islet autoantibody 
and 154 of them progressed to type 1 diabetes. Among them, the median (interquartile range) 
duration of the preclinical period was 3.6 (1.9, 6.1) years after the first positivity to any 
autoantibody. The drop-out rates among the 5,915 participants who were included in the analysis at 
1 and 5-year follow up were 10.5% and 34.6%, respectively. 
Male sex, the high-risk HLA-DQB1 genotype and familial diabetes were associated with increased 
risk of developing advanced islet autoimmunity and type 1 diabetes (Table 1). Maternal age and 
gestational age were not associated with advanced islet autoimmunity or type 1 diabetes (data not 
shown). Higher maternal education was associated with decreased risk of developing advanced islet 
autoimmunity (Table 1) but with increased risk of progressing to type 1 diabetes (Web Table 1).  
Median (interquartile range) duration of exclusive and any breastfeeding was 1.4 (0.2, 3.5) and 7.0 
(3.0, 10.0) months, respectively. The earliest supplementary foods were infant formulas, root 
vegetables (including potatoes), fruits or berries, and cereals, which were introduced at the median 
age of 1.4, 3.5, 4.0, and 5.0 months, respectively. The median age at introduction of any solid food 
was 3.5 (3.0, 4.0) months. 
Age at Introduction of Foods and Risk of Advanced Islet Autoimmunity and Type 1 Diabetes 
Duration of breastfeeding or age at introduction of any new foods were not associated with 
development of advanced islet autoimmunity, type 1 diabetes (Table 2) or progression to type 1 
diabetes among children with repeated autoantibody positivity (Web Table 2) over the 15-year 
follow-up. These associations were not affected by adjustment for HLA genotype, familial diabetes, 
child’s sex and maternal education (Change in hazard ratios (HR) due to adjustment varied between 
0.0 and 0.18). Breastfeeding at the time of introduction of each food, adjusted with age at 
introduction of each food was not associated with risk of developing islet autoimmunity, type 1 
diabetes or progression to type 1 diabetes.  
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Altogether 181 children had an early exposure to infant formula but were not in the first third of 
exclusive breastfeeding when early exposure was disregarded. Duration of exclusive breastfeeding, 
when hospital exposure to infant formula was disregarded, was not associated with advanced islet 
autoimmunity or type 1 diabetes. Shorter exclusive breastfeeding and any breastfeeding, when 
divided in quarters, were associated with increased risk of advanced islet autoimmunity, but not 
type 1 diabetes (Web Table 3). 
For the risk of advanced islet autoimmunity, we observed a statistically significant interaction for 
follow-up time with age at introduction of roots (P = 0.02), wheat, rye, oats or barley combined (P 
= 0.03), egg (P = 0.008), meat (P = 0.008) and solid foods (P = 0.046) (Table 3). In general, early 
introduction of these foods was associated with developing advanced islet autoimmunity before but 
not after the age of 3 years (Table 3). No other follow-up time-interactions were observed for age at 
introduction of foods and the risk of advanced islet autoimmunity or type 1 diabetes.  
The HLA-genotype modified the associations between the age at introduction of roots or any solid 
foods, and the risk of developing advanced islet autoimmunity, such that introduction of roots and 
solid foods at the age of 3-4 months versus after 4 months of age was associated with advanced islet 
autoimmunity only in children with the high-risk genotype (Table 4).  
The INS- genotype modified the association between age at introduction of meat and risk of 
advanced islet autoimmunity, such that early introduction of meat (OR: 3.08, 95% CI: 1.06, 8.95 for 
the first third and OR: 1.02, 95% CI: 0.55, 1.88 for the middle third versus the third third) was 
associated with advanced islet autoimmunity in children with the INS AT/TT genotype but not in 
those carrying the INS AA genotype (OR: 0.60, 95% CI: 0.30, 1.21 for the first third and OR: 0.69, 
95% CI: 0.48, 1.00 for the second third), P value for interaction = 0.046.  
The PTPN22- genotype modified the association between age at introduction of fish and risk of 
advanced islet autoimmunity with the following odds ratios (OR: 1.65, 95% CI: 0.74, 3.68 for the 
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first third and OR: 0.64, 95% CI: 0.34, 1.20 for the middle third versus the third third) in children 
with PTPN22 TT/CT genotype and (OR: 0.94, 95% CI: 0.56, 1.57 for the first, and OR: 1.37, 95% 
CI: 0.91, 2.05 for the middle third) in children with the PTPN22 CC genotype, P value for 
interaction = 0.006.  
We observed no other modifying effects of HLA-, INS- or PTPN22-genotypes on the associations 
between age at introduction of foods and the outcomes.  
Food Diversity and Risk of Advanced Islet Autoimmunity and Type 1 Diabetes 
Food diversity at age 3, 4, 6 or 12 months was not associated with the development of advanced 
islet autoimmunity or type 1 diabetes in the cohort, (Figure 1) nor with progression to type 1 
diabetes (Web Table 4). Adjustment with potential confounders did not change the results.  
We found no modifying effects of follow-up time or HLA-genotype on the associations between 
food diversity and advanced islet autoimmunity or type 1 diabetes. There was no indication of 
modifying effect of INS and PTPN22-genotypes on the associations between food diversity and 
advanced islet autoimmunity. 
DISCUSSION  
In this large prospective birth cohort of children with increased genetic risk for type 1 diabetes, 
breastfeeding, age at introduction of foods or food diversity in infancy were not consistently 
associated with developing advanced islet autoimmunity or type 1 diabetes. Further, infant feeding 
was not associated with progression to type 1 diabetes in children with persistent autoantibody 
positivity.  
This study have several strengths: First, the large study population with a higher number of children 
with advanced islet autoimmunity and type 1 diabetes than any previous prospective study, and a 
long follow-up time enabled us to study associations with sufficient statistical power. Second, 
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information on carefully and consistently assessed early diet was collected before the development 
of advanced autoimmunity or type 1 diabetes, reducing reporting bias. Finally, we were able to 
assess the possible modifying effects of follow-up duration and essential type 1 diabetes risk 
genotypes.  
The main limitation is that the amount of foods consumed at the first exposures, or the continuity of 
use was not available. The study population consisted of children at increased genetic risk for type 1 
diabetes, and whether these findings apply to the general population, is not known.  
In our previous reports, early exposure to root vegetables was associated with development of 
advanced islet autoimmunity (4, 6). In the present report with longer follow-up and larger number 
of cases with advanced islet autoimmunity, the associations were of the same direction but no more 
statistically significant. We observed time-interaction for age at introduction of some foods, and in 
general, early introduction of these foods had stronger association with advanced islet 
autoimmunity with shorter than longer follow-up. However, in general, we observed no consistent 
associations between early feeding and clinical type 1 diabetes. These results together indicate that 
if early feeding plays a role in the disease process of type 1 diabetes, the role may be most 
important in the islet autoimmunity that develops at very young age, and the association may dilute 
over time.  
Only 3 other prospective studies have explored the associations between early feeding and islet 
autoimmunity and clinical type 1 diabetes. In the DAISY Study both early (≤3 month) and late (≥7 
months) introduction of any cereal and early introduction of rice were associated with increased risk 
of islet autoimmunity (2). In the  same population both early (<4 month) and late (≥6 months) 
introduction of solid foods, late introduction of any cereal and rice/oat, and early introduction of 
fruit were associated with increased risk of type 1 diabetes (12). In the BABYDIAB/BABYDIET 
Study, early (<3 month) introduction of gluten containing cereals was associated with increased risk 
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of islet autoimmunity (2) and type 1 diabetes (8). The MIDIA Study found no association between 
age at introduction of complementary foods and risk of islet autoimmunity or type 1 diabetes (7). In 
comparison to previous studies, the current study has much higher number of children with type 1 
diabetes and infant feeding data (n=188) compared to the DAISY (n=53), MIDIA (n=25) and 
BABYDIAB/BABYDIET (n=74) studies (6-8, 12). The slightly different data collection methods 
and categorization of infant feeding data, different inclusion criteria and country-specific infant 
feeding patterns may explain the variable results.  
We found no association between duration of exclusive or any breastfeeding with advanced islet 
autoimmunity or type 1 diabetes in the main analyses. However, analyses with quarter 
categorization showed that shorter breastfeeding was associated with increased risk of advanced 
islet autoimmunity but not that of type 1 diabetes. These findings together with other studies (2, 6) 
demonstrate a potential weak protective association of breastfeeding with islet autoimmunity. To 
analyze the risk of advanced islet autoimmunity or type 1 diabetes in breastfed versus non-breastfed 
children was not possible due to the small number of non-breastfed children. 
To our knowledge, this was the first study to explore the associations between food diversity in 
infancy and the risk of islet autoimmunity or type 1 diabetes. Our results indicate that food diversity 
may not be associated with the disease process leading to type 1 diabetes. 
We found that introduction of roots and solid foods at age 3-4 months were associated with 
increased risk of developing advanced islet autoimmunity in HLA high-risk children but no such 
association was observed in moderate-risk children. In previous studies, based on limited number of 
children, there has been some indication of potential differences in the associations between age at 
introduction of cereals (2) or gluten containing cereals (3) by HLA-DR genotype, so that high-risk 
children with early introduction of cereals seemed to have the highest risk of islet autoimmunity. To 
our knowledge, this was the first study to report the modifying effect of INS and PTPN22 genotypes 
on the associations between age at introduction of solid foods and food diversity with islet 
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autoimmunity. Only weak interactions of INS and PTPN22 genotypes and age at introduction of 
meat and fish, respectively, on the risk of advanced islet autoimmunity were observed. The genetic 
interaction and subgroup analyses were exploratory and showed no consistent pattern on food 
groups or age at introduction of foods and the risk of advanced islet autoimmunity or type 1 
diabetes. These findings need confirmation from other studies before further conclusions. 
Taken our present and previous results (4, 6) as well as other studies (7, 8, 12) together, early 
introduction of foods and breastfeeding may play role in the disease process of type 1 diabetes. 
However, the inconsistent results may be due to the several simultaneous and subsequent exposures 
that may blur the associations. These include child’s genotype (10) and viral infections (20) as well 
as intakes of probiotics (21), vitamin D (22), cow’s milk (10, 23), and marine fatty acids (24). 
Finally, the disease etiology can be heterogeneous regarding the type of the first islet autoantibodies 
and progression rate to type 1 diabetes, and infant feeding may modify some immune processes 
more than others. Therefore, some existing weak associations may have escaped statistical 
significance in the present study.   
To conclude, age at introduction of foods was not associated with clinical type 1 diabetes. We 
reported for the first time associations of food diversity and advanced islet autoimmunity and type 1 
diabetes with no significant associations. 
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Table 1. Characteristics and Unadjusted Hazard Ratios (HR) and 95% Confidence Intervals (95% CI) for 
Advanced Islet Autoimmunity and Type 1 Diabetes in 5,915 Children With Increased Genetic Susceptibility 
for Type 1 Diabetes Recruited in 1996-2004, DIPP Nutrition Study, Finland.  
Characteristic All 
Children (n 
= 5,915) 
Advanced Islet Autoimmunity  
(n = 359) 
 Type 1 Diabetes (n = 188) 
 No. No. HR 95% CI  No. HR  95% CI 
Child sex        
Boys 3,146 216 1.37 1.10, 1.71  113 1.33  1.00, 1.78 
Girls 2,769 143 1   75 1  
P value   0.005a   0.05b 
HLA-DQB1riskc        
High  1,149 121 2.25 1.78, 2.84  68 2.39  1.77, 3.24 
Moderate  4,766 238 1   120 1  
P value   0.001a   0.001 b 
Familial diabetes        
Yes 343 43 2.15   1.52, 3.04  27 2.73  1.78, 4.20 
No 5,324 307 1   157 1  
Missing 248 9    4   
P value   0.001a   0.001 b 
Maternal vocational 
educationd 
       
None 386 36 1   17 1  
Vocational 
School or Course 
1,584 85 0.49 0.32, 0.74  41 0.58  0.32, 1.06 
Secondary 
vocational 
education 
2,495 138 0.46   0.31, 0.68  68 0.62  0.36, 1.08 
University 
Studies or Degree  
1,259 91 0.63 0.42, 0.95  57 1.04  0.59, 1.84 
Missing 191 9    5   
P value   0.001a   0.07 b 
Ponderal indexe        
Q1 < 26.1 1,470 95 1   47 1  
Q2 26.1–27.7 1,475 91 0.97 0.72, 1.30  53 1.12  0.76, 1.67 
Q3 27.8–29.3 1,465 88 0.92 0.68, 1.25  47 1.01  0.67, 1.51 
Q4 ≥ 29.4 1,460 81 0.85 0.63, 1.16  38 0.81  0.53, 1.24 
Missing 45 4    3   
P value   0.77a   0.50b 
Maternal smoking 
during pregnancy 
       
Yes 570 31 1.02    0.69, 1.50  15 0.79  0.45, 1.38 
No 5,146 321 1   169 1  
Missing 199 7    4   
P value   0.92a   0.41b 
Number of 
siblingsd, % 
       
0 2,675 174 1   92 1  
1 1,773 109 0.89 0.69, 1.14  60 0.98  0.71, 1.35 
2or more 1,277 68 0.75 0.56, 1.01  32 0.73  0.49, 1.08 
Missing 190 8    4   
P value   0.15a   0.26b 
Abbreviations: CI, confidence interval; HLA-DQB1, Major Histocompatibility Complex Class II DQ Beta; 
HR, hazard ratio; Q1-4, quarter 1-4.  
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*a P values are from piecewise linear log-hazard survival model (Log likelihood test);  
b P values from Cox regression analysis (Wald test); 
c High risk genotype HLA-DQB1(*02/*03:02): Moderate risk genotypes HLA-DQB1(*03:02/x); x ≠*02, 
*03:01,*06:02) 
d at the time of birth 
e Ponderal index was calculated as birth weight in kilograms divided by birth length in meters in 3rd power 
(kg/m3). 
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Table 2. Duration of Breastfeeding, Age at Introduction of Foods and Unadjusted Hazard Ratios (HR) and 
95% Confidence Intervals (95% CI) for Advanced Islet Autoimmunity and Type 1 Diabetes in Children With 
Increased Genetic Susceptibility for Type 1 Diabetes, DIPP Nutrition Study, Finland, 1996-2015. 
Age (months)  All 
children 
(n = 
5,915) 
 
Advanced Islet Autoimmunity 
(n = 359) 
 Type 1 Diabetes (n = 188) 
 No.  No. HR 95% CI  No. HR 95% CI 
Exclusive breastfeeding        
<0.5 1,860 106 1.01 0.77, 1.32  55 0.86 0.60, 1.22 
0.5–2.99 2,103 136 1.17 0.91, 1.52  65 0.88 0.63, 1.23 
>2.99 1,945 117 1   68 1  
Missing 7 0    0   
P value   0.39a   0.64b 
Any breastfeeding       
<5.0 1,896 119 1.31 1.00, 1.71  55 0.92  0.63, 1.33 
5.0–9.0 1,864 117 1.14 0.87, 1.50  64 1.09  0.76, 1.56 
>9.0 1,791 110 1   56 1  
Missing 364 13    13  
P value   0.15a   0.64b 
Cow’s milkc        
< 0.9 1,841 115 1.10 0.84, 1.45  56 0.94  0.64, 1.36 
0.9–4.0 2,185 126 1.02 0.78, 1.34  69 1.00  0.69, 1.42 
>4.0 1,755 109 1   55 1  
Missing 134 9    8   
P value   0.75a   0.93b 
Fruits or berries        
<3.5 1,586 93 1.25 0.93, 1.68  48 1.02  0.69, 1.52 
3.5–4.0 2,290 150 1.28 0.99, 1.67  76 1.13  0.79, 1.61 
4.0 1,746 100 1   51 1  
Missing 293 16    13   
P value   0.14a   0.76b 
Rootsd       
<3.0 1,163 66 1.41 0.98, 2.03  34 1.05  0.64, 1.72 
3.0–4.0 3,375 217 1.40 1.04, 1.89  111 1.19  0.79, 1.80 
>4.0 1,090 60 1   30 1  
Missing 287 16    13   
P value   0.07a   0.63b 
Wheat, rye, oats or barley        
<5.0 968 51 1.02 0.71, 1.46  21 0.68  0.40, 1.14 
5.0–5.5 3,188 205 1.19 0.91, 1.56  108 1.07  0.75, 1.52 
>5.5 1,386 85 1   44 1  
Missing 373 18    15   
P value   0.35a   0.16b 
Egg       
<8.0 1,334 84 1.19 0.88, 1.61  48 1.20  0.80, 1.80 
8.0–11.0 2,243 141 1.19 0.90, 1.55  68 1.02  0.70, 1.48 
>11.0 1,702 105 1   51 1  
Missing 636 29    21   
P value   0.40a   0.60b 
Fish       
<6.0 1,132 74 1.33 0.96, 1.83  37 1.17  0.75, 1.83 
6.0–9.0 2,652 164 1.18 0.90, 1.55  87 1.19  0.81, 1.73 
>9.0 1,543 93 1   43 1  
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Missing 588 28    21   
P value   0.21a   0.66b 
Meat       
<5.0 470 30 1.16 0.76, 1.78  13 0.82  0.45, 1.50 
5.0–5.5 3,372 199 1.00 0.78, 1.28  104 0.93  0.67, 1.28 
>5.5 1,697 112 1   56 1  
Missing 376 18    15   
P value   0.75a   0.86b 
Solid foodse       
< 3.0 1,566 86 1.29 0.90, 1.85  43 0.90  0.56, 1.45 
3.0–4.0 3,191 206 1.38 1.00, 1.90  105 1.09  0.71, 1.66 
> 4.0 896 51 1   27 1  
Missing 262 16    13   
P value   0.13a   0.57b 
Abbreviations: CI, confidence interval; HR, hazard ratio.  
aP values are from piecewise linear log-hazard survival model (Log likelihood test);  
bP values from Cox regression analysis (Wald test);  
cCow’s milk includes cow’s milk based infant formulas as well as any other foods including cow’s milk;  
dRoots include carrots, potatoes and turnips 
eSolid foods include roots, fruits or berries, cereals, meat, fish, egg, cabbage, spinach, beetroot and lettuce. 
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 Table 3. Age at Introduction of Foods and Unadjusted Hazard Ratios (HR) and 95% Confidence Intervals (95% CI) for Advanced Islet Autoimmunity by 
Follow-up Time, DIPP Nutrition Study, Finland, 1996-2015. 
Age (months)  Advanced Islet Autoimmunity P value for interaction 
  0-3 years   3.1-6 years   > 6 years   
  n  HR 95% CI n HR 95% CI n HR 95% CI  
Rootsa          0.02b 
<3.0 27 2.37  1.38, 4.07 20 1.17  0.68, 1.99 19 0.95  0.54, 1.68  
3.0–4.0 83 2.26  1.46, 3.50 66 1.15  0.78, 1.69 68 1.01  0.67, 1.53  
>4.0 15 1  19 1  26 1   
P value  < 0.001c  0.75c  0.98c  
Wheat, rye, oats or barley           0.03b 
<5.0 14 1.04  0.57, 1.92 15 0.80  0.45, 1.43 22 1.12  0.66, 1.89  
5.0–5.5 82 1.82  1.25, 2.67 62 0.96  0.67, 1.38 61 0.88  0.59, 1.32  
>5.5 28 1  28 1  29 1   
P value  0.004c  0.75c  0.62c  
Egg          0.008b 
<8.0 38 2.03  1.32, 3.13 26 1.03  0.65, 1.63 20 0.69  0.41, 1.16  
8.0–11.0 50 1.73  1.14, 2.61 46 1.04  0.71, 1.52 45 0.91  0.61, 1.36  
>11.0 35 1  31 1  39 1   
P value  0.02c  0.98c  0.35c  
Meat          0.008b 
<5.0 8 1.14  0.53, 2.42 10 1.06  0.54, 2.07 12 1.25  0.66, 2.36  
5.0–5.5 81 1.62  1.13, 2.33 60 0.81  0.58, 1.15 58 0.71  0.49, 1.04  
>5.5 35 1  35 1  42 1   
P value  0.03c  0.46c  0.10c  
Solid foodsd          0.046b 
< 3.0 37 2.33  1.39, 3.91 23 0.93  0.55, 1.57 23 0.90  0.53, 1.53  
3.0–4.0 76 2.18  1.38, 3.47 65 1.15  0.77, 1.72 65 0.99  0.64, 1.53  
> 4.0 12 1  17 1  22 1   
P value  < 0.001c  0.63c  0.91c  
Abbreviations: CI, confidence interval; HR, hazard ratio.  
aRoots include carrots, potatoes and turnips 
bP values for interaction (categorized age at introduction of food*continuous follow-up time) 
cP values are from piecewise linear log-hazard survival model (Log likelihood test) including interaction terms 
dSolid foods include roots, fruits or berries, cereals, meat, fish, egg, cabbage, spinach, beetroot and lettuce.  
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Table 4. Age at Introduction of Roots and Solid Foods and Unadjusted Hazard Ratios (HR) and 95% Confidence Intervals (95% CI) for Advanced Islet 
Autoimmunity and Type 1 Diabetes by HLA-DQ genotype, DIPP Nutrition Study, Finland, 1996-2015. 
 HLA Moderate riska  HLA High riskb   HLA Moderate riska  HLA High riskb  
  Advanced Islet 
Autoimmunity 
  Advanced Islet 
Autoimmunity 
  Type 1 Diabetes  Type 1 Diabetes  
Age, 
months 
n total n 
cases 
HR 95% CI  n 
total 
n 
cases 
HR 95% CI  P 
value 
n 
cases 
HR 95% CI  n 
cases 
HR 95% CI P 
value 
Rootsc         0.001d      0.010d 
<3.0 936 52 1.50 0.99, 2.27 227 14 1.11 0.52, 2.38  28 1.23 0.69, 2.19 6 0.63 0.23, 1.76  
3.0–4.0 2,741 132 1.10  0.77, 1.56 634 85 2.49 1.40, 4.42  64 0.96 0.58, 1.60 47 1.82  0.90, 3.71  
>4.0 871 45 1   219 15 1    21 1   9 1   
P value   0.12e    < 0.001 e     0.56f   0.017f  
Solid 
foodsg 
        0.002d      0.038d 
< 3.0 1,266 67 1.40 0.93, 2.13 300 19 0.97  0.47, 2.00  34 1.07 0.61, 1.87 9 0.57 0.23, 1.43  
3.0–4.0 2,581 125 1.13  0.77, 1.65 610 81 2.12 1.17, 3.84  61 0.94 0.56, 1.60 44 1.40 0.68, 2.87  
> 4.0 721 37 1   175 14 1    18 1   9 1   
P value   0.23e    0.001e     0.84f   0.038f  
Abbreviations: CI, confidence interval; HLA, human leucocyte antigen; HR, hazard ratio. 
a Moderate risk includes genotypes HLA-DQB1(*03:02/x); x ≠*02, *03:01, *06:02) 
b High risk includes genotypes HLA-DQB1(*02/*03:02) 
cRoots include carrots, potatoes and turnips 
dP values for interaction term (categorized age at introduction of food*HLA genotype) 
e Overall P values are from piecewise linear log-hazard survival model including HLA-genotype and interaction terms (Likelihood Ratio test) 
f Overall P values Cox regression analysis including HLA-genotype and interaction terms (Wald test) 
gSolid foods include roots, fruits or berries, cereals, meat, fish, egg, cabbage, spinach, beetroot and lettuce.  
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Figure 1. Food Diversity at Age of 3, 4, 6, and 12 Months and the Unadjusted Hazard Ratios (95% 
Confidence Intervals) for Advanced Islet Autoimmunity and Type 1 Diabetes in Children With Increased 
Genetic Susceptibility for Type 1 Diabetes, DIPP Nutrition Study, Finland, 1996-2015. 
 
CI, confidence interval; HR, hazard ratio; The food diversity is the sum of the following 13 foods/food 
groups that the child had started to consume: cow’s milk or cow’s milk based infant formula (combined); 
potato; carrot; turnip; fruits or berries (combined); cereals (rye, wheat, oats, or barley combined); other 
cereals; meat; fish; egg; cabbage; spinach or beetroot (combined); and lettuce. A) HRs and 95% CIs for the 
risk of advanced islet autoimmunity are from piecewise linear log-hazard survival model; B) HRs and 95% 
CIs for type 1 diabetes are from Cox regression analysis. 
 
 
 
 
 
Web Figure 1. Flowchart of the Study Recruitment and Formation of the Present Study Population 
Recruited in 1996-2004, DIPP Nutrition Study, Finland. 
 
 
 
  
Web Appendix 1 
Piecewise Linear Log-Hazard Survival Model 
Since autoantibodies were screened in 3 to 12 month intervals, the timing of the advanced islet autoimmunity 
is after the last negative assessment of the outcome and before the first positive assessment. Therefore, 
advanced islet autoimmunity outcome is interval censored, i.e. the advanced islet autoimmunity time T of the 
subject can’t be directly observed, but can be observed to lie within some time interval. A piecewise linear 
log-hazard survival model, which allows a flexible estimation of the baseline hazard function (and the 
distribution of the event times) from the data, was used to build the model for the interval censored outcome 
observed at arbitrary times. The corresponding likelihood was constructed as described before (1).  
To be more specific, the time scale was divided into three intervals [0,2), [2,4) and [4,∞), and linear log-
hazards in the intervals were assumed. The results were not sensitive to the particular choice of intervals 
used. The hazard function of the model was assumed to be given by 
𝑙𝑙𝑙𝑙𝑙𝑙ℎ0(𝑡𝑡) =  𝛼𝛼 +  𝛽𝛽1𝑡𝑡 +  𝛽𝛽2(𝑡𝑡 − 2)𝐼𝐼(𝑡𝑡 > 2) +  𝛽𝛽3(𝑡𝑡 − 4)𝐼𝐼(𝑡𝑡 > 4). 
Figure S1 suggests that the hazard for advanced islet autoimmunity starts to increase from the birth and 
reaches the highest intensity at approximately two years of age. After that period, the hazard steadily 
declines to less than one third of the peak value of the hazard.  
To estimate the effects of the covariates on the hazard, we used the conventional representation of the Cox 
proportional hazards model, which means that the hazard ratios have their conventional interpretation 
ℎ𝑖𝑖(𝑡𝑡) = exp{𝛾𝛾(𝑡𝑡)′𝑋𝑋(𝑡𝑡)}ℎ0(𝑡𝑡). 
Time-dependent exposures were allowed to influence the risk in a given observational interval only if the 
exposure could reasonably be expected to affect the subject for at least half of the length of the interval. 
Observation intervals beyond advanced islet autoimmunity positivity did not contribute to the analyses. 
Random effects for family were introduced to accommodate dependence among siblings, and these were 
assumed to follow a normal distribution with mean zero and with variance estimated from the data. 
 
 
Web Figure 2. Estimated Log-Hazard and Hazard Functions for Advanced Islet Autoimmunity, DIPP 
Nutrition Study, Finland. 
 
 
 
  
Web Table 1. Characteristics and Unadjusted Hazard Ratios (HR) and 95% Confidence Intervals (95% CI) 
for Progression to Type 1 Diabetes in 975 Children With Persistent Islet Autoimmunity, DIPP Nutrition 
Study, Finland, 1996-2015. 
Characteristic Children With 
Persistent Islet 
Autoimmunity 
Progression to Type 1 Diabetes 
(n = 154) 
 (n = 975) No. HR 95% CI 
Child sex    
Boys 537 96 1.35 0.98, 1.87 
Girls 438 58   
P value   0.07a 
HLA-DQB1riskb    
High  221 50 1.67 1.19, 2.33 
Moderate 754 104 1  
P value   0.003a 
Familial type 1 diabetes    
Yes 78 24 2.03 1.31, 3.14 
No 875 128 1  
Missing 22 2   
P value   0.002a 
Maternal vocational educationc    
None 79 10 1  
Vocational school or course 241 33 1.15 0.57, 2.34 
Secondary vocational education 414 58 1.20 0.61, 2.34 
University studies or degree  223 50 1.98 1.01, 3.91 
Missing 18 3   
P value   0.02a 
Maternal age, yearsc    
<25 167 24 1  
25-29 332 55 1.29 0.80, 2.09 
30-34 281 41 1.18 0.71, 1.95 
≥35 195 34 1.33 0.79, 2.24 
P value   0.70a 
Gestational age, weeks     
Q1 <38.9 219 45 1.41 0.91, 2.17 
Q2 38.9–39.9 251 34 0.98 0.62, 1.55 
Q3 40.0–40.8 225 33 1.05 0.66, 1.68 
Q4 ≥ 40.9 266 38 1  
Missing 14 4   
P value   0.31a 
Ponderal indexd    
Q1 < 26.1 239 40 1  
Q2 26.1–27.7 238 44 1.11 0.72, 1.71 
Q3 27.8–29.3 252 38 1.00 0.64, 1.56 
Q4 ≥ 29.4 233 29 0.75 0.47, 1.22 
Missing 13 3   
P value   0.44a 
Maternal smoking during pregnancy    
Yes 82 12 0.82 0.45, 1.47 
No 861 138 1  
Missing 32 4   
P value   0.50a 
Number of siblingsc, %    
0 441 74 1  
1 281 54 1.23 0.87, 1.75 
2 or more 233 24 0.68 0.43, 1.07 
Missing 20 2   
P value   0.05a 
Abbreviations: CI, confidence interval; HLA-DQB1, Major Histocompatibility Complex Class II DQ Beta; 
HR, hazard ratio; Q1-4, quartile 1-4.  
aP values from Cox regression analysis (Wald test).  
bHigh risk genotype HLA-DQB1(*02/*03:02): Moderate risk genotypes HLA-DQB1(*03:02/x); x ≠*02, 
*03:01,*06:02) 
cat the time of birth 
dPonderal index was calculated as birth weight in kilograms divided by birth length in meters in 3rd power 
(kg/m3). 
  
Web Table 2. Duration of Breastfeeding, Age at Introduction of Foods and Unadjusted Hazard Ratios (HR) 
and 95% Confidence Intervals (95% CI) for Progression to Type 1 Diabetes in 975 Children with Persistent 
Islet Autoimmunity, DIPP Nutrition Study, Finland, 1996-2015. 
Age (months)  Children With Persistent 
Islet Autoimmunity 
Progression to Type 1 Diabetes 
 
 n=975 n=154 HR 95% CI  
Exclusive breastfeeding      
<0.5 311 47 0.86  0.58, 1.26 
0.5–2.99 342 56 0.90  0.63, 1.31 
>2.99 321 51 1  
Missing 1 0   
P value   0.72a 
Any breastfeeding     
<5.0 314 46 0.81  0.55, 1.20 
5.0–9.0 322 56 1.04  0.72, 1.50 
>9.0 329 51 1  
Missing 10 1   
P value   0.40a 
Cow’s milkb     
< 0.9 317 49 0.90  0.61, 1.32 
0.9–4.0 339 55 0.88  0.61, 1.28 
>4.0 316 50 1  
Missing 3 0   
P value   0.77a 
Fruits or berries     
<3.5 249 41 1.06  0.70, 1.62 
3.5–4.0 392 68 1.18  0.81, 1.72 
4.0 319 43 1  
Missing 15 2   
P value   0.66a 
Rootsc     
<3.0 165 29   
3.0–4.0 606 99 1.11  0.66, 1.88 
>4.0 190 24 1.09  0.71, 1.69 
Missing 14 2 1  
P value   0.91a 
Wheat, rye, oats or barley      
<5.0 143 19 0.82  0.48, 1.40 
5.0–5.5 567 95 1.05  0.73, 1.53 
>5.5 248 37 1  
Missing 17 3   
P value   0.58a 
Egg     
<8.0 216 44 1.41  0.93, 2.12 
8.0–11.0 420 64 1.07  0.73, 1.57 
>11.0 310 43 1  
Missing 29 3   
P value   0.21a 
Meat     
<5.0 68 12 1.03  0.56, 1.91 
5.0–5.5 576 93 1.00  0.72, 1.41 
>5.5 314 46 1  
Missing 17 3   
P value   0.99a 
Solid foodsd     
< 3.0 232 37 1.01  0.60, 1.70 
3.0–4.0 563 94 1.18  0.75, 1.87 
> 4.0 166 21 1  
Missing 14 2   
P value   0.61a 
Abbreviations: CI, confidence interval; HR, hazard ratio; 
aP values from Cox regression analysis (Wald test);   
bCow’s milk includes cow’s milk based infant formulas as well as any other foods including cow’s milk.  
cRoots include carrots, potatoes and turnips 
dSolid foods include roots, fruits or berries, cereals, meat, fish, egg, cabbage, spinach, beetroot and lettuce.  
  
Web Table 3. Unadjusted Hazard Ratios (HR) and 95% Confidence Intervals (95% CI) for Advanced Islet 
Autoimmunity and Type 1 Diabetes According to Duration of Breastfeeding in Quarters in Children With 
Increased Genetic Susceptibility for Type 1 Diabetes, DIPP Nutrition Study, Finland, 1996-2015. 
Age (months)  Advanced Islet Autoimmunity  Type 1 Diabetes 
 HR 95% CI  HR 95% CI 
Exclusive breastfeeding      
< 0.23 1.20 0.85, 1.69  0.77  0.50,  1.19 
0.23–1.37 1.61 1.15, 2.23  1.07 0.72,  1.58 
1.38–3.5 1.47 1.06, 2.02  0.85 0.56,  1.28 
> 3.5 1   1  
P value < 0.001a   0.39b  
Any breastfeeding      
< 3.5 1.31 0.96, 1.80  0.89  0.59,  1.35 
3.5–6.9 1.37 1.01, 1.86  1.10  0.74,  1.64 
7.0–10.5 0.99 0.72, 1.36  0.83 0.54,  1.25 
> 10.5 1   1  
P value < 0.001a   0.56b  
Abbreviations: CI, confidence interval; HR, hazard ratio.  
aP values are from piecewise linear log-hazard survival model (Log likelihood test);  
bP values are from Cox regression analysis (Wald test);  
 
  
Web Table 4. Food Diversity at Age of 3,4, 6, and 12 Months and the Unadjusted Hazard Ratios (95% 
Confidence Intervals) for Progression to Type 1 Diabetes in Children With Persistent Islet Autoimmunity, 
The DIPP Nutrition Study, Finland, 1996-2015. 
No. of Food 
Itemsa 
Children With Persistent 
Islet Autoimmunity 
Progression to Type 1 Diabetes 
(n=154) 
 (n=975) No. HR 95% CI 
3 months    
0 265 43 1.25     0.82, 1.92 
1–2 459 74 1.14     0.77, 1.68 
>2 249 37 1 
Missing 2 0  
P value   0.59b 
4 months    
0 110 17 1.20     0.69, 2.08 
1–2 166 21 0.97     0.60, 1.58 
3–4 329 58 1.27     0.88, 1.81 
>4 368 58 1 
Missing 2 0  
P value   0.52b 
6 months    
0–4 67 9 0.78     0.33, 1.83 
5–6 132 21 1.08     0.66, 1.76 
7–8 486 76 1.06     0.74, 1.51 
>8 288 48 1 
Missing 2 0  
P value   0.89b 
12 months    
0–7 56 10 1.63     0.76, 3.51 
8–9 134 22 1.29     0.78, 2.14 
10–11 444 76 1.34     0.94, 1.90 
>11 339 48 1 
Missing 2 0  
P value   0.33b 
Abbreviations: CI, confidence interval; HR, hazard ratio;  
aThe food diversity is the sum of the following 13 foods/food groups that the child had started to consume: 
cow’s milk or cow’s milk based infant formula (combined); potato; carrot; turnip; fruits or berries 
(combined); cereals (rye, wheat, oats, or barley combined); other cereals; meat; fish; egg; cabbage; spinach 
or beetroot (combined); and lettuce and was categorized in tertiles or quartiles.  
bP values are from Cox regression analysis (Wald test) 
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